Trade NGEN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
NervGen Pharma Corp. (NGEN) is trading at US$2.05, down 9.69% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$199.99M. Over the past 52 weeks, NGEN has traded between US$1.58 and US$6.30. On Syfe you can trade NGEN with $0 commission and add it to your watchlist.
| Previous close | US$2.27 |
|---|---|
| Market cap | US$199.99M |
| 52-week range | US$1.58 – US$6.30 |
| Volume | 606.26K |
| Exchange | US |
Add to Watchlist
Set Price Alert
NervGen Pharma Corp.
NervGen Pharma Corp. operates as a clinical stage biotech company. It engages in the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury and other neurotraumatic and neurologic conditions. The company was founded by Harold Punnett and William Joseph Radvak on January 19, 2017 and is headquartered in Vancouver, Canada.
Year: 2019
--Leerink Partners Initiates Coverage on NervGen Pharma With Outperform Rating, $10 Price Target
Jul 13, 11:35 AM · MT Newswires
TD Cowen Initiates NervGen Pharma at Buy
Jun 11, 10:26 AM · MT Newswires
Top Premarket Decliners
May 22, 11:42 AM · MT Newswires
NervGen Pharma Prices $60 Million Share Offering
May 22, 7:11 AM · MT Newswires
NervGen Pharma Names Keith Vendola CFO
Apr 27, 1:38 PM · MT Newswires
NervGen Pharma Corp. (NGEN) stock is trading at US$2.05, -9.69% from the previous close of US$2.27.
The market cap for NervGen Pharma Corp. (NGEN) stock is approximately US$199.99M.
The 52-week high for NervGen Pharma Corp. (NGEN) stock is US$6.30.
The 52-week low for NervGen Pharma Corp. (NGEN) stock is US$1.58.
NervGen Pharma Corp. (NGEN) does not currently pay a dividend.
Stay on top of NGEN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
